The multidrug resistance phenotype
1988
Understanding Multidrug Resistance in Cancer
Editorial
Evidence: low
Author Information
Author(s): S.B. Kaye
Primary Institution: C.R.C. Department of Medical Oncology, University of Glasgow, UK
Hypothesis
Resistant tumor cells expressing the MDR phenotype possess an enhanced form of a protective cellular mechanism characteristic of certain normal cells.
Conclusion
The study highlights the complexity of multidrug resistance in cancer and the potential for therapeutic strategies to overcome it.
Supporting Evidence
- Multidrug resistance (MDR) is a major cause of treatment failure in common cancers.
- P glycoprotein is linked to the cellular mechanisms of drug resistance.
- Recent studies suggest that the phosphorylation state of P glycoprotein may modulate its function.
Takeaway
Some cancer cells can become resistant to drugs, making treatment harder. Scientists are trying to understand why this happens and how to fix it.
Limitations
Data on the correlation between MDR phenotype and clinical drug resistance is still too preliminary.
Want to read the original?
Access the complete publication on the publisher's website